Streetbeat News

Products Services

APXI

APx Acquisition Corp. I (NASDAQ:APXI), OmnigenicsAI Corp, and MultiplAI Health Ltd have entered into a Business Combination Agreement to create a global AI-driven genomics platform. The merger aims to list OmnigenicsAI on Nasdaq under the ticker 'OMNI'. This strategic combination will focus on delivering personalized health insights and clinical guidance through AI and precision medicine, covering prevention, early detection, diagnostics, and treatment. The merger is expected to close mid-year, subject to APx's shareholder approval and other conditions.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 12:27 pm

MESO

STOK

VKTX

Shares of Stoke Therapeutics, Viking Therapeutics, and Mesoblast saw significant increases after positive developments in their respective clinical trials and FDA communications. Stoke Therapeutics reported encouraging Phase 1/2a data for STK-001 in treating Dravet syndrome, leading to a 101% surge in its shares. Viking Therapeutics announced successful results from its Phase 1 trial of VK2735, resulting in a 21% increase in its stock price. Mesoblast shares jumped 49% after the FDA deemed its Phase 3 study data sufficient to support a Biologics License Application for remestemcel-L in treating pediatric patients with steroid-refractory acute graft versus host disease.

Portfolio Pulse from ryanfaloona@benzinga.com

March 26, 2024 | 12:26 pm

SNPMF

TTE

TotalEnergies SE (TTE) and China Petroleum and Chemical Corporation (SNPMF) have signed an agreement to develop a Sustainable Aviation Fuel (SAF) production unit in China, aiming for an annual production of 230,000 tons. This collaboration aligns with both companies' strategies to provide low carbon solutions and marks a significant step towards TotalEnergies' goal of producing 1.5 million tons of SAF by 2030. TTE shares saw a 0.53% increase in premarket trading.

Portfolio Pulse from Lekha Gupta

March 26, 2024 | 12:23 pm

OPTT

Ocean Power Technologies (OPTT) has received purchase orders totaling $1.5 million for its WAM-V USV (Unmanned Surface Vehicles) in Latin America. This development signifies a growing interest and potential expansion in the Latin American market for OPTT's innovative marine technology solutions.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 12:20 pm

GNSS

Genasys Inc. (NASDAQ:GNSS) announced its partnership in Project AWARE, funded by the EU's Horizon Europe Programme, to develop a solution for extending Galileo EWSS public safety warnings to various devices. This project aims to enhance public warning systems by integrating the solution into display panels, indoor warning systems, and acoustic devices, including Genasys' own Protect ACOUSTICS. The initiative involves multiple partners and will demonstrate its capabilities with the Republic of Slovenia Administration for Civil Protection and Disaster Relief.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 12:16 pm

SOBR

SOBR Safe, Inc. has expanded into the psychological services and therapy sector by partnering with The Neeble Diamond Group, which will use SOBR Safe's SOBRcheck technology to screen for alcohol presence before client therapy sessions.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 12:15 pm

AQMS

Aqua Metals (NASDAQ:AQMS) and 6K Energy have signed a strategic supply agreement to create North America's first sustainable lithium battery supply chain. Aqua Metals will supply sustainably recycled battery materials to 6K Energy, which will use them to manufacture low-carbon cathode active material. This collaboration aims to support the US's efforts to expand manufacturing capabilities and establish resilient supply chains while reducing carbon emissions. The materials supplied under this agreement are estimated to be worth over $50 million annually once both companies' facilities reach capacity. The partnership also aligns with the Inflation Reduction Act, offering domestic content incentives.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 12:15 pm

MESO

Mesoblast shares surged following the FDA's indication that the clinical data from its Phase 3 study MSB-GVHD001 is sufficient to support the submission of a Biologics License Application for remestemcel-L, aimed at treating pediatric patients with steroid-refractory acute graft versus host disease.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 12:14 pm

TNON

Tenon Medical, Inc. (NASDAQ:TNON) announced significant progress in a post-market study of its Catamaran SI Joint Fusion System for treating sacroiliac joint disorders. Preliminary results at 12-month follow-up show 100% fusion response, marked improvements in pain scores, disability, and high patient satisfaction. Study enrollment is expected to complete soon, with patients evaluated up to 24 months.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 12:11 pm

NXPL

NextPlat Corp (NASDAQ:NXPL) announced the acquisition of Outfitter Satellite Inc. through an all-cash transaction, aiming to more than double its North American technology e-commerce product sales and recurring revenue. The acquisition, expected to close on April 1, 2024, will also enhance profitability through improved business efficiencies and support future domestic and international operations. This move is part of NextPlat's growth strategy to expand its technology and healthcare e-commerce offerings in the U.S. and globally.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 12:10 pm